SUNPHARMA — Sun Pharmaceutical Industries Balance Sheet
0.000.00%
- IN₹4.42tn
- IN₹4.24tn
- IN₹484.97bn
- 92
- 12
- 94
- 77
Annual balance sheet for Sun Pharmaceutical Industries, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | R2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 113,666 | 95,633 | 127,169 | 151,477 | 191,135 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 99,257 | 93,248 | 121,851 | 129,598 | 132,557 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 316,542 | 304,421 | 348,646 | 398,619 | 434,331 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 112,263 | 111,715 | 111,689 | 113,537 | 113,001 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 682,525 | 676,667 | 698,078 | 807,436 | 854,629 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 157,064 | 161,456 | 172,085 | 199,064 | 169,838 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 229,880 | 212,040 | 217,966 | 247,482 | 217,961 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 452,645 | 464,628 | 480,112 | 559,954 | 636,668 |
Total Liabilities & Shareholders' Equity | 682,525 | 676,667 | 698,078 | 807,436 | 854,629 |
Total Common Shares Outstanding |